Trials / Completed
CompletedNCT02461290
Rituximab Therapy in Follicular Lymphoma in Combination With Chemotherapy - REFLECT 1
Open, Noninterventional, Multicentre Trial of Rituximab in Combination With Chemotherapy (CVP, CHOP or FCM) Chemotherapy in Patients With Follicular Lymphoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 99 (actual)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to evaluate the safety profile and tolerability of rituximab in combination with different chemotherapy regimens.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Chemotherapy | |
| DRUG | Rituximab |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2015-06-03
- Last updated
- 2015-09-30
- Results posted
- 2015-09-30
Locations
6 sites across 1 country: Serbia
Source: ClinicalTrials.gov record NCT02461290. Inclusion in this directory is not an endorsement.